跳至主要内容
临床试验/IRCT2016120130508N2
IRCT2016120130508N2已完成未知

Therapeutic Effects of Heparin on Treatment of chronic diabetic foot ulcers: a randomized blind controlled clinical trial

Guilan University of Medical Sciences0 个研究点目标入组 136 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Inclusion Criteria
  • 1- Recent chronic neuropathic diabetic foot ulcer (less than 10 days)
  • 2- Ulcer Wagner grade is 1 or debrided patients or limited amputation with Wagner grade of 2, 3, and 4
  • 3- ABI > 0.9 (not ischemic and neuroischemic)
  • 4- Open or debrided ulcer or limited amputation
  • 5- Having informed consent for study inclusion
  • Exclusion Criteria
  • 1- Chronic diabetic foot ulcers caused by ischemia
  • 2- Under treatment with anticoagulant therapy at the time of study inclusion
  • 3- contraindication of low molecular weight heparin administration, including severe renal failure (creatinine lower than 30 ml/min (hepatic failure of Child-Pugh class B or C, having bleeding disorders and proliferative diabetic retinopathy subject to bleeding risk
  • 4- Active osteomyelitis
  • 5- Systemic sepsis

排除标准

  • 未提供

研究者

发起方
Guilan University of Medical Sciences

相似试验